PortfoliosLab logo

BioNTech SE (BNTX)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in BioNTech SE in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $91,220 for a total return of roughly 812.20%. All prices are adjusted for splits and dividends.

BNTX (BioNTech SE)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BNTX

BioNTech SE

Popular comparisons: BNTX vs. MRNA, BNTX vs. VTI


BioNTech SE had a return of -14.66% year-to-date (YTD) and -21.90% in the last 12 months. Over the past 10 years, BioNTech SE had an annualized return of 89.85%, outperforming the S&P 500 benchmark which had an annualized return of 9.13%.

1 month-6.78%-0.66%
6 months-1.38%5.67%
1 year-21.90%-10.89%
5 years (annualized)89.85%9.13%
10 years (annualized)89.85%9.13%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioNTech SE Sharpe ratio is -0.42. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BNTX (BioNTech SE)
Benchmark (^GSPC)

Dividend History

BioNTech SE granted a 1.65% dividend yield in the last twelve months. The annual payout for that period amounted to $2.11 per share.


Dividend yield


Monthly Dividends

The table displays the monthly dividend distributions for BioNTech SE. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BNTX (BioNTech SE)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the BioNTech SE. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioNTech SE is 73.17%, recorded on Oct 20, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-73.17%Aug 10, 2021303Oct 20, 2022
-58.07%Mar 19, 202019Apr 15, 202068Jul 22, 202087
-44.5%Jul 23, 202029Sep 1, 202048Nov 9, 202077
-37.07%Dec 11, 202014Dec 31, 202069Apr 13, 202183
-36.7%Jan 9, 202044Mar 12, 20203Mar 17, 202047
-22.91%Nov 11, 20205Nov 17, 20208Nov 30, 202013
-20.51%Dec 18, 20192Dec 19, 20198Jan 2, 202010
-20.25%Oct 23, 20194Oct 28, 201919Nov 22, 201923
-19.58%May 4, 20213May 6, 202118Jun 2, 202121
-15.59%Jun 10, 20215Jun 16, 202122Jul 19, 202127

Volatility Chart

Current BioNTech SE volatility is 26.10%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BNTX (BioNTech SE)
Benchmark (^GSPC)